To identify the metabolic pathways affected by the activity of USP9x, metabolite levels were measured using targeted capillary electrophoresis time-of-flight/mass spectrometry (CE-TOF/MS) in USP9x-depleted lung cancer cells. This evidence concerns the gene USP9X and lung carcinoma.